Contact Us
Home Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007

October 24, 2007
PDF Version

PALO ALTO, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its third quarter 2007 financial results on Tuesday, November 6, 2007, following the close of the U.S. financial markets. Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss the quarterly results and company updates on November 6, 2007, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available through November 20, 2007.

Investors may participate in the conference call by dialing 1-866-770-7120 in the U.S., or 1-617-213-8065 outside the U.S., and entering passcode 57344568. A replay of this call will be available until November 20, 2007 at 1-888-286-8010 (U.S.), or 1-617-801-6888 (international), using the passcode 41294935.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com and institutional investors can access the call via www.streetevents.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information, please visit www.JazzPharmaceuticals.com.

    Contacts:

    Jazz Pharmaceuticals, Inc.
    Jim Karrels
    Executive Director, Finance
    650-496-2800
    investorinfo@jazzpharma.com

    BCC Partners
    Karen L. Bergman, 650-575-1509
    Michelle Corral, 415-794-8662

SOURCE  Jazz Pharmaceuticals, Inc.
    -0-                             10/24/2007
    /CONTACT:  Jim Karrels, Executive Director, Finance of Jazz
Pharmaceuticals, Inc., +1-650-496-2800, investorinfo@jazzpharma.com; or Karen
L. Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC
Partners/
    /Web site: http://www.JazzPharmaceuticals.com /
    (JAZZ)

CO:  Jazz Pharmaceuticals, Inc.
ST:  California
IN:  MTC BIO HEA
SU:  CCA

CR-JK
-- CLW046 --
4712 10/24/2007 09:00 EDT http://www.prnewswire.com